Krystal Biotech (KRYS) Long-Term Deferred Tax (2025 - 2026)

Krystal Biotech has disclosed Long-Term Deferred Tax across 2 years of filings, most recently posting $22.8 million for Q1 2026.

• Long-Term Deferred Tax for Q1 2026 came in at $22.8 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $22.8 million (changed N/A YoY), and the FY2025 annual result was $22.8 million, changed N/A from the prior year.
• Long-Term Deferred Tax came in at $22.8 million for Q1 2026 at Krystal Biotech, roughly flat from $22.8 million in the prior quarter.
• In the past five years, Long-Term Deferred Tax ranged from a high of $24.7 million in Q3 2025 to a low of $22.8 million in Q4 2025.